YOSHIDA Mitsuzi | Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd. : Central Research Laboratories, Meiji Seika Kaisha, Ltd. : National Cancer Center Research Institute.
スポンサーリンク
概要
- 同名の論文著者
- Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd. : Central Research Laboratories, Meiji Seika Kaisha, Ltd. : National Cancer Center Research Institute.の論文著者
関連著者
-
YOSHIDA MITSUZI
Pharmacology Division, National Cancer Center Research Institute
-
Yoshida Mitsuzi
Pharmacology Division National Cancer Center Research Institute
-
YOSHIDA Mitsuzi
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd. : Central Research Laboratories, Meiji Seika Kaisha, Ltd. : National Cancer Center Research Institute.
-
Hoshi Akio
Pharmacology Division National Cancer Center Research Institute
-
Hoshi Akio
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Hoshi Akio
国立がんセンター
-
IKARASHI Yoshinori
Pharmacology Division, National Cancer Center Research institute
-
KATO Kazunori
Pharmacology Division, National Cancer Center Research institute
-
WAKASUGI Hiro
Pharmacology Division, National Cancer Center Research institute
-
Ikarashi Yoshinori
Pharmacology Division National Cancer Center Research Institute
-
Wakasugi Hiro
Pharmacology Division National Cancer Center Research Institute
-
Hoshi A
National Cancer Center Resarch Institute
-
FUKUYASU Harumi
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
Fukuyasu H
Meiji Seika Kaisha Ltd. Yokohama Jpn
-
Fukuyasu Harumi
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Iigo M
National Cancer Res. Inst. Tokyo
-
Iigo Masaaki
Cancer Prevention Basic Res. Project National Cancer Center Res. Inst.
-
Iigo Masaaki
Pharmacology Division National Cancer Center Research Institute
-
Iigo Masaaki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Kato Kazunori
Pharmacology Division National Cancer Center Research Institute
-
NAKAJIMA Shokichi
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.
-
TOKUZEN REIKO
Pharmacology Division, National Cancer Center Research Institute
-
FUKUKAWA KIYOFUMI
Faculty of Pharmaceutical Sciences, Hokkaido University
-
UEDA TOHRU
Faculty of Pharmaceutical Sciences, Hokkaido University
-
YOSHIDA MITSUZI
National Cancer Center Research Institute
-
SATO Yasumi
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.
-
KAZUNO Yuzo
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.
-
Ishiguro Masaji
Loboratory Of Chemistry For Natural Products Tokyo Institute Of Technology
-
Kazuno Yuzo
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Sato Yasumi
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Tokuzen R
National Cancer Center Research Inst. Tokyo Jpn
-
Yoshida M
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Ueda T
Process Development Center Sharp Corporation
-
Tokuzen Reiko
Pharmacology Division National Cancer Center Research Institute
-
Fukukawa K
Toyo Jozo Co. Ltd. Shizuoka Jpn
-
Nakajima S
Meiji Seika Kaisha Ltd. Kawasaki‐shi Jpn
-
Nakajima Shokichi
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd.
-
Ueda Tohru
Faculty Of Bioresource Sciences Akita Prefectural University
著作論文
- ANTITUMOR ACTIVITY OF DERIVATIVES OF NEPLANOCIN A IN VIVO AND IN VITRO
- A Simple Method for Predicting Modes of Actions of Antitumor Agents
- U1B3.3 monoclonal antibody recognizes a precursor of NK1.1+ cytotoxic T cells generated by interleukin-2